Acute clinical hepatitis by immune restoration in a human immunodeficiency virus/hepatitis B virus co-infected patient receiving antiretroviral therapy
被引:11
作者:
Rouanet, I
论文数: 0引用数: 0
h-index: 0
机构:Hop G Doumergue, Serv Med Interne A Pneumol, F-30000 Nimes, France
Rouanet, I
Peyrière, H
论文数: 0引用数: 0
h-index: 0
机构:Hop G Doumergue, Serv Med Interne A Pneumol, F-30000 Nimes, France
Peyrière, H
Mauboussin, JM
论文数: 0引用数: 0
h-index: 0
机构:Hop G Doumergue, Serv Med Interne A Pneumol, F-30000 Nimes, France
Mauboussin, JM
Terrail, N
论文数: 0引用数: 0
h-index: 0
机构:Hop G Doumergue, Serv Med Interne A Pneumol, F-30000 Nimes, France
Terrail, N
Vincent, D
论文数: 0引用数: 0
h-index: 0
机构:Hop G Doumergue, Serv Med Interne A Pneumol, F-30000 Nimes, France
Vincent, D
机构:
[1] Hop G Doumergue, Serv Med Interne A Pneumol, F-30000 Nimes, France
[2] CHU Montpellier, Lapeyronie Hosp, Pharmacovigilance Ctr, Montpellier, France
We describe a human immunodeficiency virus (HIV)-infected patient with chronic active hepatitis B. The patient presented with acute clinical hepatitis during highly active antiretroviral therapy concomitant with immunovirological improvement of HIV infection. The hepatitis resolved within a few weeks despite the pursuit of antiretroviral drugs. Hepatitis B tests, which remained unchanged after two cycles of interferon alfa therapy and continuous administration of lamivudine, were improved with the clearance of hepatitis B virus (HBV) early antigen (HBeAg), the detection of antibody to HBV early antigen (HBeAb) and the undetectability of serum HBV DNA. Several months after this episode, HBV and HIV tests are still controlled. (C) 2003 Lippincott Williams Wilkins.